Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Lung Neoplasms 3Peripheral Nervous System Diseases 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Infections 1Healthy Subject 1

Interventions

Testosterone 2Laser Therapy 2Coconut Oil 2Water 1Vitamin E 1Transcranial Direct Current Stimulation 1Testosterone Propionate 1Sodium Chloride 1Replens 1Physical Therapy Modalities 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dyspareunia × Fish Oils × Clear all
NCT02150525 2018-08-09

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
52 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡